Saliva-based diagnostics have emerged as a transformative approach in medical testing, offering a non-invasive and efficient ...

A number of promising approaches involving molecules, stem cells, and inorganic chemistry are possible for the near future.

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

The FDA has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta.

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

Dyne Therapeutics is a clinical stage biotech concern with just over $700 million of cash on its balance sheet. Learn more ...

The Kowalinski group at EMBL Grenoble discovered notable differences between the nuclear cap-binding complex in trypanosomes and humans, a critical component in cellular RNA metabolism. Trypanosomes ...

Researchers at the University of Copenhagen and NTU Singapore have discovered that RNA damage, not DNA damage, is the real trigger for the acute effec ...

Researchers at the Technion-Israel Institute of Technology have discovered a unique genetic mechanism that provides cells with rapid and efficient protection against viruses. The findings could lead ...

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

The integration will enable Leica’s BOND staining systems to simultaneously detect RNA and protein targets on the same tissue ...

The highly anticipated 2025 ASC Student Supercomputer Challenge (ASC25) launch event was held recently in Beijing. The ...